Halma PLC has announced its half-year results for the period ending September 30, 2023. The company reported record revenue, profit, and dividend growth, driven by its Sustainable Growth Model and long-term growth drivers. Revenue increased by 9% to £950.5 million, while adjusted earnings before interest and taxation (EBIT) rose by 7% to £189.9 million. Adjusted profit before taxation increased by 3% to £177.5 million, and adjusted earnings per share grew by 4% to 36.90p.

The company's performance was supported by healthy contributions from recent acquisitions, which added over 5% to revenue and profit growth. The adjusted EBIT margin remained resilient at 20.0%, and the return on sales was 18.7%. Halma continued its strategic investment to support future growth, with R&D investment increasing by 5% to £52 million and five acquisitions completed in the financial year to date.

Halma achieved revenue growth in all sectors, with the safety sector making strong progress, the environmental and analysis sector reporting good growth, and the healthcare sector experiencing modest growth. However, the healthcare sector's flat organic constant currency (OCCY) revenue was offset by OEM customer destocking and budgetary caution at healthcare providers.

The company also reported revenue growth in all regions except Asia Pacific, with strong growth in the USA and Mainland Europe. The interim dividend per share increased by 7%, reflecting the board's confidence in the group's growth prospects.

Looking ahead, Halma expects to make further progress in the second half of the year and deliver good organic constant currency revenue growth for the full year. The group's order intake remains ahead of the comparable period last year, and the current expectation is for full-year adjusted profit before taxation to be in line with analyst consensus expectations.